#eupraxia
Latest news and interesting information about eupraxia.
Stifel Initiates Eupraxia with Buy Rating
Stifel initiated coverage on Eupraxia Pharmaceuticals with a Buy rating and $25 target. Diffusphere platform and strong finances highlighted.
...
